Importance:
Clinical practice guidelines state there is insufficient evidence to support advising patients with peripheral artery disease (PAD) to participate in a home-based walking exercise program.
Objective:
To determine whether a home-based walking exercise program that uses a group-mediated cognitive behavioral intervention, incorporating both group support and self-regulatory skills, can improve functional performance compared with a health education control group in patients with PAD with and without intermittent claudication.
Design, Setting, And Patients:
Randomized controlled clinical trial of 194 patients with PAD, including 72.2% without classic symptoms of intermittent claudication, performed in Chicago, Illinois between July 22, 2008, and December 14, 2012.
Interventions:
Participants were randomized to 1 of 2 parallel groups: a home-based group-mediated cognitive behavioral walking intervention or an attention control condition.
Main Outcomes And Measures:
The primary outcome was 6-month change in 6-minute walk performance. Secondary outcomes included 6-month change in treadmill walking, physical activity, the Walking Impairment Questionnaire (WIQ), and Physical and Mental Health Composite Scores from the 12-item Short-Form Health Survey.
Results:
Participants randomized to the intervention group significantly increased their 6-minute walk distance ([reported in meters] 357.4 to 399.8 vs 353.3 to 342.2 for those in the control group; mean difference, 53.5 [95% CI, 33.2 to 73.8]; P < .001), maximal treadmill walking time (intervention, 7.91 to 9.44 minutes vs control, 7.56 to 8.09; mean difference, 1.01 minutes [95% CI, 0.07 to 1.95]; P = .04), accelerometer-measured physical activity over 7 days (intervention, 778.0 to 866.1 vs control, 671.6 to 645.0; mean difference, 114.7 activity units [95% CI, 12.82 to 216.5]; P = .03), WIQ distance score (intervention, 35.3 to 47.4 vs control, 33.3 to 34.4; mean difference, 11.1 [95% CI, 3.9 to 18.1]; P = .003), and WIQ speed score (intervention, 36.1 to 47.7 vs control, 35.3-36.6; mean difference, 10.4 [95% CI, 3.4 to 17.4]; P = .004).
Conclusion And Relevance:
A home-based walking exercise program significantly improved walking endurance, physical activity, and patient-perceived walking endurance and speed in PAD participants with and without classic claudication symptoms. These findings have implications for the large number of patients with PAD who are unable or unwilling to participate in supervised exercise programs.
Trial Registration:
clinicaltrials.gov Identifier: NCT00693940.
Citing Articles
A 6-Minute Limb Function Assessment for Therapeutic Testing in Experimental Peripheral Artery Disease Models.
Palzkill V, Tan J, Moparthy D, Tice A, Ferreira L, Ryan T
JACC Basic Transl Sci. 2025; 10(1):88-103.
PMID: 39906594
PMC: 11788496.
DOI: 10.1016/j.jacbts.2024.08.011.
A Hybrid Rehabilitation Program for Adults with Peripheral Artery Disease (HY-PAD): A Pre-Post Intervention Study to Assess Its Feasibility.
Terada T, Hausen M, Mir H, Reed J, Coutinho T
CJC Open. 2025; 7(1):110-119.
PMID: 39872645
PMC: 11763241.
DOI: 10.1016/j.cjco.2024.09.017.
Evaluation of Peripheral Circulatory Changes Following Hydrotherapy and Controlled Physical Training in Patients with Atherosclerotic Lower Limb Ischemia.
Kapusta J, Kapusta A, Babicki M, Irzmanski R
Life (Basel). 2025; 14(12.
PMID: 39768286
PMC: 11677352.
DOI: 10.3390/life14121578.
Brazilian Society of Angiology and Vascular Surgery guidelines on peripheral artery disease.
Erzinger F, Polimanti A, Pinto D, Murta G, Cury M, da Silva R
J Vasc Bras. 2024; 23:e20230059.
PMID: 39493832
PMC: 11530000.
DOI: 10.1590/1677-5449.202300592.
Addressing Psychosocial Care Needs in Women with Peripheral Artery Disease.
Mubarak E, Cleman J, Romain G, Mena-Hurtado C, Smolderen K
Curr Cardiol Rep. 2024; 26(10):1085-1095.
PMID: 39073508
DOI: 10.1007/s11886-024-02106-6.
Efficacy of comprehensive structured exercise program on claudication pain and quality of life in type 2 diabetes mellitus with peripheral arterial disease.
Arora E, Maiya G, Devasia T, Bhat R, Kamath G
J Diabetes Metab Disord. 2024; 23(1):1305-1313.
PMID: 38932870
PMC: 11196545.
DOI: 10.1007/s40200-024-01426-2.
Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial.
McDermott M, Martens C, Domanchuk K, Zhang D, Peek C, Criqui M
Nat Commun. 2024; 15(1):5046.
PMID: 38871717
PMC: 11176364.
DOI: 10.1038/s41467-024-49092-5.
A 6-minute Limb Function Assessment for Therapeutic Testing in Experimental Peripheral Artery Disease Models.
Palzkill V, Tan J, Tice A, Ferriera L, Ryan T
bioRxiv. 2024; .
PMID: 38585832
PMC: 10996543.
DOI: 10.1101/2024.03.21.586197.
Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study.
Fanaroff A, Coratti S, Farraday D, Norton L, Rareshide C, Zhu J
Am Heart J. 2024; 270:95-102.
PMID: 38354997
PMC: 10947804.
DOI: 10.1016/j.ahj.2024.02.003.
The Role of Physiotherapy in Peripheral Artery Disease in Patients With Diabetes Mellitus: A Narrative Review.
Herrera D, Rueda Capistrani D, Obando Vera S, Sanchez Cruz C, Linarez Nunez K, Banegas D
Cureus. 2024; 16(1):e52019.
PMID: 38344599
PMC: 10854460.
DOI: 10.7759/cureus.52019.
Benefits of Integrating Technology into Home Exercise Therapy in Patients with Lower Extremity Peripheral Artery Disease.
Rotundu A, Oancea A, Mastaleru A, Costache A, Cumpat C, Abdulan I
J Clin Med. 2023; 12(24).
PMID: 38137704
PMC: 10744306.
DOI: 10.3390/jcm12247635.
Effect of a monitored home-based exercise program combined with a behavior change intervention and a smartphone app on walking distances and quality of life in adults with peripheral arterial disease: the WalkingPad randomized clinical trial.
Silva I, Moreira C, Pedras S, Oliveira R, Veiga C, Moreira L
Front Cardiovasc Med. 2023; 10:1272897.
PMID: 38075956
PMC: 10702743.
DOI: 10.3389/fcvm.2023.1272897.
Exercise Training for Patients With Peripheral Arterial Occlusive Disease.
Ingwersen M, Kunstmann I, Oswald C, Best N, Weisser B, Teichgraber U
Dtsch Arztebl Int. 2023; 120(51-52):879-885.
PMID: 38019155
PMC: 10859744.
DOI: 10.3238/arztebl.m2023.0231.
Effects of Long-Term Home Exercise in Participants With Peripheral Artery Disease.
Gardner A, Montgomery P, Wang M, Liang M
J Am Heart Assoc. 2023; 12(21):e029755.
PMID: 37929770
PMC: 10727372.
DOI: 10.1161/JAHA.122.029755.
Home-Based Walking Exercise and Supervised Treadmill Exercise in Patients With Peripheral Artery Disease: An Individual Participant Data Meta-Analysis.
Thangada N, Zhang D, Tian L, Zhao L, Rejeski W, Ho K
JAMA Netw Open. 2023; 6(9):e2334590.
PMID: 37733346
PMC: 10514734.
DOI: 10.1001/jamanetworkopen.2023.34590.
Study Design, Rationale, and Methodology for Promote Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The PROVE Trial.
Whipple M, Pfammatter A, Spring B, Rejeski W, Treat-Jacobson D, Domanchuk K
J Am Heart Assoc. 2023; 12(17):e031182.
PMID: 37642035
PMC: 10547361.
DOI: 10.1161/JAHA.123.031182.
Longitudinal Pathways Between Physical Activity, Depression, and Perceived Stress in Peripheral Artery Disease.
Yazgan I, Bartlett V, Romain G, Cleman J, Petersen-Crair P, Spertus J
Circ Cardiovasc Qual Outcomes. 2023; 16(8):544-553.
PMID: 37470195
PMC: 10561081.
DOI: 10.1161/CIRCOUTCOMES.122.009840.
The effect of telephone health coaching and remote exercise monitoring for peripheral artery disease (TeGeCoach) on health care cost and utilization: results of a randomized controlled trial.
Heider D, Rezvani F, Matschinger H, Dirmaier J, Harter M, Herbarth L
Eur J Health Econ. 2023; 25(4):615-629.
PMID: 37428355
PMC: 11136827.
DOI: 10.1007/s10198-023-01616-4.
Home-Based Exercise Therapy in the Management of Intermittent Claudication: A Systematic Review and Meta-Analysis.
Twomey A, Khan Z
Cureus. 2023; 15(5):e39206.
PMID: 37384085
PMC: 10294279.
DOI: 10.7759/cureus.39206.
Relation of non-exercise walking activity with exercise performance in patients with peripheral artery disease: NEW activity for PAD.
Mays R, Kahnke R, Schorr E, Treat-Jacobson D
J Vasc Nurs. 2023; 41(1):1-5.
PMID: 36898798
PMC: 10009898.
DOI: 10.1016/j.jvn.2022.11.002.